The R16G ADRB2 polymorphism correlated with decreased FEV1 and COPD severity [175], and also correlated with insulin sensitivity in an obese postmenopausal cohort of women in another study [176]. Here, ADRB2 is linked to chronic obstructive pulmonary disease.